These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17174510

  • 1. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
    Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, Lee KM.
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
    [Abstract] [Full Text] [Related]

  • 2. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH.
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD, Uh Y, Lee G, Lim K, Kim JB, Jeong SH.
    APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
    [Abstract] [Full Text] [Related]

  • 4. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.
    Coudron PE.
    J Clin Microbiol; 2005 Aug; 43(8):4163-7. PubMed ID: 16081966
    [Abstract] [Full Text] [Related]

  • 5. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
    Pitout JD, Le PG, Moore KL, Church DL, Gregson DB.
    Clin Microbiol Infect; 2010 Feb; 16(2):165-70. PubMed ID: 19456838
    [Abstract] [Full Text] [Related]

  • 6. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
    Jeong SH, Song W, Park MJ, Kim JS, Kim HS, Bae IK, Lee KM.
    Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
    [Abstract] [Full Text] [Related]

  • 7. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY, Ng SY, Teo L, Koh Y, Teok CH.
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [Abstract] [Full Text] [Related]

  • 8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH.
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Sabia C, Gargiulo R, Sarti M.
    New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136
    [Abstract] [Full Text] [Related]

  • 11. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Apr; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 12. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M, Piekarska K, Gierczyński R.
    Med Dosw Mikrobiol; 2012 Apr; 64(4):285-95. PubMed ID: 23484420
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 3 phenotypic-detection methods for identifying plasmid-mediated AmpC beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis strains.
    Lee W, Jung B, Hong SG, Song W, Jeong SH, Lee K, Kwak HS.
    Korean J Lab Med; 2009 Oct; 29(5):448-54. PubMed ID: 19893354
    [Abstract] [Full Text] [Related]

  • 14. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S, Altanlar N.
    Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
    Ko SY, Chung JW, Song AJ, Yoon NS, Sung H, Kim MN.
    Korean J Lab Med; 2009 Feb; 29(1):35-40. PubMed ID: 19262076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.
    Aragón LM, Mirelis B, Miró E, Mata C, Gómez L, Rivera A, Coll P, Navarro F.
    J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096
    [Abstract] [Full Text] [Related]

  • 18. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, Siddiqui S.
    J Infect Dev Ctries; 2009 May 01; 3(4):285-94. PubMed ID: 19759492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H, Midilli K, Oğünç D, Ozen N, Ongüt G, Dağlar D, Mutlu D, Ozhak B, Colak D.
    Mikrobiyol Bul; 2008 Oct 01; 42(4):545-51. PubMed ID: 19149075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.